BRIEF published on 11/04/2025 at 15:54, 10 months 12 days ago The Vanguard Group Discloses Position in JTC plc Form 8.3 Disclosure Takeover Code Vanguard Group JTC Plc
BRIEF published on 11/04/2025 at 15:53, 10 months 12 days ago The Vanguard Group Discloses Position in Avadel Pharmaceuticals Form 8.3 Shareholding Vanguard Takeover Panel Avadel Pharmaceuticals
PRESS RELEASE published on 11/04/2025 at 15:52, 10 months 12 days ago Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated The Vanguard Group, Inc. discloses a 10.61% stake in Qualcomm Incorporated as of 03 Nov 2025. Also making disclosures related to Alphawave IP Group plc Disclosure Vanguard Group Stake Qualcomm Alphawave IP Group
BRIEF published on 11/04/2025 at 15:51, 10 months 12 days ago The Vanguard Group Discloses Position in Mural Oncology plc Form 8.3 Irish Takeover Panel The Vanguard Group Shareholding Disclosure Mural Oncology Plc
PRESS RELEASE published on 11/04/2025 at 15:51, 10 months 12 days ago Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc. The Vanguard Group, Inc. discloses 7.47% ownership in American Axle & Manufacturing Holdings, Inc. Form 8.3 submitted on 04-Nov-2025 Form 8.3 Vanguard Group Ownership Disclosure Financial Disclosure American Axle
BRIEF published on 11/04/2025 at 15:50, 10 months 12 days ago The Vanguard Group's Interest in Greencore Group plc The Vanguard Group Stake Disclosure Stock Transactions Investment Transparency Greencore Group Plc
PRESS RELEASE published on 11/04/2025 at 15:49, 10 months 12 days ago Form 8.3 - The Vanguard Group, Inc.: JTC plc The Vanguard Group, Inc. discloses a 5.05% stake in JTC plc. Position disclosure under Rule 8.3 of the Takeover Code Disclosure Takeover Code Vanguard Group Stake JTC Plc
PRESS RELEASE published on 11/04/2025 at 15:48, 10 months 12 days ago Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc The Vanguard Group, Inc. discloses a 5.67% interest in Avadel Pharmaceuticals plc on 03 November 2025 The Vanguard Group, Inc. Irish Takeover Panel Interest Disclosure Stock Holdings Avadel Pharmaceuticals Plc
BRIEF published on 11/04/2025 at 15:48, 10 months 12 days ago Vanguard Discloses Position in Spire Healthcare Securities Form 8.3 Takeover Code Spire Healthcare Vanguard
PRESS RELEASE published on 11/04/2025 at 15:46, 10 months 12 days ago Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc The Vanguard Group, Inc. discloses 1.67% ownership in Mural Oncology plc. No other party disclosures made. Details on Form 8.3 The Vanguard Group, Inc. Form 8.3 Ownership Disclosure Financial Disclosure Mural Oncology Plc
Published on 09/16/2026 at 23:45, 54 minutes ago Galway Metals Settles Claim by Former Employee with Cash and Share Payments
Published on 09/16/2026 at 21:30, 3 hours 9 minutes ago Torq Completes $1.7 Million Private Placement
Published on 09/16/2026 at 16:55, 7 hours 44 minutes ago CORRECTION FROM SOURCE: SLAM Reports 1.60% Copper Equivalent Over 14.45 Meters in Hole GW26-33; Trenching Gold-Antimony Targets on Moose Lake Project
Published on 09/16/2026 at 15:00, 9 hours 39 minutes ago 2026 Canada's Top 40 Under 40(R) Honourees Announced
Published on 09/16/2026 at 14:00, 10 hours 39 minutes ago Ameriwest Awaits Bornite Core Assay Results and Provides Q3 2026 Corporate Update
Published on 09/16/2026 at 23:45, 54 minutes ago WESCAN GOLDFIELDS COMMENCES UAV MAGNETIC AND LIDAR SURVEYS AT MUNRO LAKE PROJECT
Published on 09/16/2026 at 22:33, 2 hours 5 minutes ago EQS-Adhoc: Bilfinger adjusts outlook for 2026 and resolves program “Agile”
Published on 09/16/2026 at 21:15, 3 hours 24 minutes ago Gastech 2026 in Bangkok Converts Global Energy Ambition into Billions of Dollars in Deals
Published on 09/16/2026 at 20:27, 4 hours 11 minutes ago EQS-Adhoc: REPLOID Group AG resolves to issue convertible notes in an aggregate principal amount of up to EUR 30 million
Published on 09/16/2026 at 19:05, 5 hours 34 minutes ago EcoFlow to showcase its open home energy ecosystem at Solar & Storage Live Zurich 2026
Published on 09/16/2026 at 17:45, 6 hours 54 minutes ago Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 17 hours 39 minutes ago bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
Published on 09/15/2026 at 18:00, 1 day 6 hours ago Report on the Combined General Meeting of the 10th of September 2026
